WO2010053329A3 - 올리고 펩티드를 수식한 신규한 양이온성 지질, 그의 제조 방법 및 그를 포함하는 전달체 - Google Patents

올리고 펩티드를 수식한 신규한 양이온성 지질, 그의 제조 방법 및 그를 포함하는 전달체 Download PDF

Info

Publication number
WO2010053329A3
WO2010053329A3 PCT/KR2009/006567 KR2009006567W WO2010053329A3 WO 2010053329 A3 WO2010053329 A3 WO 2010053329A3 KR 2009006567 W KR2009006567 W KR 2009006567W WO 2010053329 A3 WO2010053329 A3 WO 2010053329A3
Authority
WO
WIPO (PCT)
Prior art keywords
delivery system
nucleic acid
same
cationic lipid
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2009/006567
Other languages
English (en)
French (fr)
Other versions
WO2010053329A2 (ko
Inventor
오유경
이한영
한수은
심가용
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Korea University Research and Business Foundation
SNU R&DB Foundation
Original Assignee
Korea University Research and Business Foundation
SNU R&DB Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea University Research and Business Foundation, SNU R&DB Foundation filed Critical Korea University Research and Business Foundation
Publication of WO2010053329A2 publication Critical patent/WO2010053329A2/ko
Publication of WO2010053329A3 publication Critical patent/WO2010053329A3/ko
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/12Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82BNANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B1/00Nanostructures formed by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

본 발명은 올리고 펩티드를 수식한 신규한 양이온성 지질, 그의 제조 방법 및 그를 포함하는 핵산 전달체를 제공한다. 본 발명의 양이온성 지질은 핵산 전달 체의 제조를 위해 사용된다. 본 발명의 양이온성 지질은 제조 및 정제 공정이 간편 하여 대량 생산시의 경제성이 높다. 또한, 본 발명의 양이온성 지질을 포함한 핵산 전달체는 세포 내로 전달하고자 하는 리보핵산, 작은 간섭 리보핵산, 안티센스 올 리고핵산, 핵산 앱타머(aptamer) 등의 올리고 핵산 의약을 세포 내로 수송하는 효 율을 현저히 증강시킬 뿐만 아니라, 세포 독성을 감소시켜 핵산 의약의 치료 효능 을 증강시키는 용도로 유용하게 사용된다.
PCT/KR2009/006567 2008-11-10 2009-11-10 올리고 펩티드를 수식한 신규한 양이온성 지질, 그의 제조 방법 및 그를 포함하는 전달체 Ceased WO2010053329A2 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020080111275A KR100909786B1 (ko) 2008-11-10 2008-11-10 올리고 펩티드를 수식한 신규한 양이온성 지질, 그의 제조 방법 및 그를 포함하는 전달체
KR10-2008-0111275 2008-11-10

Publications (2)

Publication Number Publication Date
WO2010053329A2 WO2010053329A2 (ko) 2010-05-14
WO2010053329A3 true WO2010053329A3 (ko) 2010-08-19

Family

ID=41338037

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2009/006567 Ceased WO2010053329A2 (ko) 2008-11-10 2009-11-10 올리고 펩티드를 수식한 신규한 양이온성 지질, 그의 제조 방법 및 그를 포함하는 전달체

Country Status (2)

Country Link
KR (1) KR100909786B1 (ko)
WO (1) WO2010053329A2 (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011116152A2 (en) * 2010-03-16 2011-09-22 Sanford -Burnham Medical Research Institute Delivery of agents using interfering nanoparticles
CN103760428B (zh) * 2014-01-24 2016-01-27 上海同耀通信技术有限公司 人体组织液的模拟液
US20170354672A1 (en) * 2016-05-16 2017-12-14 The Board Of Regents Of The University Of Texas System Compositions for the delivery of trna as nanoparticles and methods of use therewith
US12357580B2 (en) 2018-06-19 2025-07-15 The Board Of Regents Of The University Of Texas System Lipid nanoparticle compositions for delivery of mRNA and long nucleic acids
US12509552B2 (en) * 2021-04-08 2025-12-30 The Curators Of The University Of Missouri Lipidated poly(amino acid) nanostructures

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4600526A (en) * 1982-09-22 1986-07-15 Centre National de la Recherche Schientifique (C N R S) Lipopeptides, their preparation and their application as emulsifiers
KR100807060B1 (ko) * 2007-08-28 2008-02-25 고려대학교 산학협력단 신규한 양이온성 지질, 그의 제조 방법 및 그를 포함하는전달체

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4600526A (en) * 1982-09-22 1986-07-15 Centre National de la Recherche Schientifique (C N R S) Lipopeptides, their preparation and their application as emulsifiers
KR100807060B1 (ko) * 2007-08-28 2008-02-25 고려대학교 산학협력단 신규한 양이온성 지질, 그의 제조 방법 및 그를 포함하는전달체

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"ACS Symposium Series, 1989, 384 (Polym. Assoc. Struct.)", 1989, ISSN: 0097-6156, article GALLOT, B. ET AL.: "Liquid crystalline phases and emulsifying properties of block copolymer hydrophobic aliphatic and hydrophilic peptidic chains", pages: 116 - 128 *

Also Published As

Publication number Publication date
KR100909786B1 (ko) 2009-07-29
WO2010053329A2 (ko) 2010-05-14

Similar Documents

Publication Publication Date Title
MX350764B (es) Liposomas con relacion nitrogeno:fosfato (n:p) util para el suministro de moleculas de arn.
WO2008118212A3 (en) In vivo delivery of double stranded rna to a target cell
MX2010009465A (es) Una celula fermentadora de azucar pentosa.
WO2010014895A3 (en) Nanoparticle compositions for nucleic acids delivery system
EP3418386A3 (en) Compositions and methods for inhibiting gene expression of hepatitis b virus
WO2009028824A3 (en) A novel cationic lipid, a preparation method of the same and a delivery system comprising the same
NZ593618A (en) Gnaq targeted dsrna compositions and methods for inhibiting expression
NZ592867A (en) Compositions and methods for inhibiting expression of transthyretin
WO2012046085A3 (en) Methods of inducing insulin production
HK1200089A1 (en) Biodegradable lipids for the delivery of active agents
WO2009086428A3 (en) Methods and compositions for increasing gene expression
WO2010053329A2 (ko) 올리고 펩티드를 수식한 신규한 양이온성 지질, 그의 제조 방법 및 그를 포함하는 전달체
WO2012170957A8 (en) Retinoid-liposomes for enhancing modulation of hsp47 expression
WO2013173757A8 (en) Method for treating non-small cell lung cancer
NZ612285A (en) Enhanced immune response in bovine species
PH12013502600A1 (en) Rabies virus like particle production in plants
NZ700897A (en) Lowering saturated fatty acid content of plant seeds
WO2007137156A3 (en) Rnai modulation of aha and therapeutic uses thereof
WO2013058482A3 (ko) 표적지향 및 치료가 가능한 다기능성 핵산 기반 항암제, 이의 제조 방법 및 이를 포함하는 항암제 조성물
WO2007128477A3 (en) SHORT INTERFERING RIBONUCLEIC ACID (siRNA) FOR ORAL ADMINISTRATION
MY185050A (en) A pentose sugar fermenting cell
PH12013502402A1 (en) Method for treating non-small cell lung cancer
MX2011008542A (es) Molecula de acido nucleico de un racimo biosintetico que codifica sintasas peptidicas no ribosomales y usos de la misma.
WO2011054939A3 (en) Compositions and methods for inhibiting expression of kif10 genes
WO2011132854A3 (ko) 지방산 생합성 경로를 이용한 지방산 함량 개선을 위한 이종 대장균 및 제조방법

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09825012

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09825012

Country of ref document: EP

Kind code of ref document: A2